Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Bulletin Du Cancer|February 4, 2006
[PI3K-AKT-mTOR pathway inhibitors]Alexis Cortot, Jean-Pierre Armand, Jean-Charles Soria
Journal of Clinical Medicine|October 20, 2018
Physician Empathy Interacts with Breaking Bad News in Predicting Lung Cancer and Pleural Mesothelioma Patient Survival: Timing May Be CrucialSophie Lelorain, Alexis Cortot, Véronique Christophe, et al.
Nuclear Medicine Communications|May 3, 2014
Higher predictive value of tumour and node [18F]-FDG PET metabolic volume and TLG in advanced lung cancer under chemotherapyAnaïs Olivier, Gregory Petyt, Alexis Cortot, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|October 15, 2019
Profiles of caregivers most at risk of having unmet supportive care needs: Recommendations for healthcare professionals in oncologyAnne-Sophie Baudry, Laurence Vanlemmens, Amelie Anota, et al.
Therapeutic Advances in Medical Oncology|December 3, 2025
Pembrolizumab versus pembrolizumab plus chemotherapy in patients with PDL1 ⩾50% advanced non-small-cell lung cancer, depending on tumor aggressiveness and clinical impactMarine Lejeune, Eric Wasielewski, Vincent Leroy, et al.
Patient Education and Counseling|February 8, 2018
In which context is physician empathy associated with cancer patient quality of life?Sophie Lelorain, Stéphane Cattan, Florian Lordick, et al.
In Vivo (Athens, Greece)|February 21, 2013
M14K and M38K malignant pleural mesothelioma cell lines preserve the same claudin-based phenotype in vivoSiham Chaouche-Mazouni, Marie-Christine Copin, Philippe Lassalle, et al.
Annales De Pathologie|February 7, 2017
[Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers]Michaël Duruisseaux, Isabelle Rouquette, Julien Adam, et al.
Bulletin Du Cancer|April 12, 2026
[Metabolic and cardiovascular disorders with lorlatinib: How to detect and manage them in practice?]Jennifer Arrondeau, Stéphane Ederhy, Christophe Héron, et al.
Therapeutic Advances in Medical Oncology|February 12, 2025
Impact of corticosteroids on the efficacy of first-line pembrolizumab plus chemotherapy in patients with advanced non-small-cell lung cancerAmytis Roboubi, Eric Wasielewski, Soraya Bordier, et al.
Pageof 5